MAPT and Alzheimer disease: Some have hypothesized that the facilitation of AD-related tau hyperphosphorylation occurs due to overactivity of glycogen synthase kinase-3 (GSK-3) [62], an insulin signaling kinase whose active form phosphorylates tau.